logo
ResearchBunny Logo
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation

Medicine and Health

Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation

M. S. Zinter, C. C. Dvorak, et al.

This groundbreaking study by Matt S. Zinter and colleagues reveals critical insights into lung injury post-hematopoietic cell transplantation. Through analysis of BAL fluid from 229 pediatric patients, the research identifies dangerous bacterial and viral patterns that could lead to fatal outcomes. These findings open avenues for personalized diagnostics and treatment strategies that may significantly improve survival rates in patients undergoing HCT.

00:00
00:00
~3 min • Beginner • English
Abstract
Hematopoietic cell transplantation (HCT) uses cytotoxic chemotherapy and/or radiation followed by intravenous infusion of stem cells to cure malignancies, bone marrow failure and inborn errors of immunity, hemoglobin and metabolism. Lung injury is a known complication of the process, due in part to disruption in the pulmonary microenvironment by insults such as infection, alloreactive inflammation and cellular toxicity. How microorganisms, immunity and the respiratory epithelium interact to contribute to lung injury is uncertain, limiting the development of prevention and treatment strategies. Here we used 278 bronchoalveolar lavage (BAL) fluid samples to study the lung microenvironment in 229 pediatric patients who have undergone HCT treated at 32 children's hospitals between 2014 and 2022. By leveraging paired microbiome and human gene expression data, we identified high-risk BAL compositions associated with in-hospital mortality (P=0.007). Disadvantageous profiles included bacterial overgrowth with neutrophilic inflammation, microbiome contraction with epithelial fibroproliferation and profound commensal depletion with viral and staphylococcal enrichment, lymphocytic activation and cellular injury, and were replicated in an independent cohort from the Netherlands (P = 0.022). In addition, a broad array of previously occult pathogens was identified, as well as a strong link between antibiotic exposure, commensal bacterial depletion and enrichment of viruses and fungi. Together these lung-immune system-microorganism interactions clarify the important drivers of fatal lung injury in pediatric patients who have undergone HCT. Further investigation is needed to determine how personalized interpretation of heterogeneous pulmonary microenvironments may be used to improve pediatric HCT outcomes.
Publisher
Nature Medicine
Published On
Jul 01, 2024
Authors
Matt S. Zinter, Christopher C. Dvorak, Madeline Y. Mayday, Gustavo Reyes, Miriam R. Simon, Emma M. Pearce, Hanna Kim, Peter J. Shaw, Courtney M. Rowan, Jeffrey J. Auletta, Paul L. Martin, Kamar Godder, Christine N. Duncan, Nahal R. Lalefar, Erin M. Kreml, Janet R. Hume, Hisham Abdel-Azim, Caitlin Hurley, Geoffrey D. E. Cuvelier, Amy K. Keating, Muna Qayed, James S. Killinger, Julie C. Fitzgerald, Rabi Hanna, Kris M. Mahadeo, Troy C. Quigg, Prakash Satwani, Paul Castillo, Shira J. Gertz, Theodore B. Moore, Benjamin Hanisch, Aly Abdel-Mageed, Rachel Phelan, Dereck B. Davis, Michelle P. Hudspeth, Greg A. Yanik, Birgitta A. Versluys, Caroline A. Lindemans, Jaap J. Boelens, Joseph L. DeRisi
Tags
lung injury
hematopoietic cell transplantation
bronchoalveolar lavage
pediatric patients
in-hospital mortality
microbiome
antibiotics
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny